A Look at the Potential of Precision Medicine for Pediatric Respiratory Diseases
May 16th 2021Genome-wide association studies are building the potential for precision medicine for children with respiratory diseases, but the progress also comes with challenges related to cost and issues with early screening, according to speakers at the ATS 2021 International Conference.
Read More
Efficacy of COVID-19 Vaccines in Real-World Settings Even Better Than Expected, Fauci Says
May 16th 2021Anthony Fauci, MD, told attendees at the ATS 2021 International Conference that the real-world evidence of vaccines against SARS-CoV-2, the virus that causes COVID-19, is even better than expected.
Read More
Dr Laura Crotty Alexander Previews Research on EVALI, Vaping Diseases in the Time of COVID
May 11th 2021Laura Crotty Alexander, MD, ATSF, outlines her presentation on e-cigarette or vaping product use-associated lung injury (EVALI) and other vaping diseases in the time of COVID-19 and beyond.
Read More
Dr Michelle Cloutier Previews NAEPP Updates to Asthma Management Guidelines
May 10th 2021Michelle M Cloutier, MD, is professor emerita at UCONN Health in Farmington, Connecticut, and chair of the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee Expert Panel Working Group.
Read More
Screen More Former Smokers for Lung Cancer, Study Suggests
May 23rd 2018Data from the Mayo Clinic suggest that smokers who have quit longer than 15 years may need to be screened for lung cancer, yet they fall outside the window recommended by the United States Preventive Services Task Force.
Read More
Medicaid Expansion Linked to Decline in ICU Stays, Study at ATS Finds
May 23rd 2018Researchers based at the University of Michigan compared patients admitted to the intensive care unit (ICU) in Medicaid expansion states with those in nonexpansion states, focusing on 18 specific conditions identified as severe illnesses that could be avoided through better preventive care.
Read More
Legal Marijuana Industry Grows Amid Unanswered Questions for Public Health
May 22nd 2018Two scientists taking part in a session on addiction and pulmonary health outlined existing evidence about marijuana's effects on chronic obstructive pulmonary disease, emphysema, chronic bronchitis, and cancer. But one speaker warned there are too few longitudinal studies in this area.
Read More
Understanding Environmental Disparities in Lung Disease—and What Can Be Done
May 21st 2018A session at the American Thoracic Society 2018 International Conference examined the factors that contribute to disparities and potential partnerships between doctors and lawyers on behalf of patients.
Read More
Attendees at the American Thoracic Society 2018 International Conference, meeting in San Diego, California, heard details that led to FDA's recent expansion of the indication for GlaxoSmithKline's Trelegy Ellipta, including findings that the once-daily combination also provides significant mortality benefits over a dual therapy that is often the combination patients with chronic obstructive pulmonary disease (COPD) are taking when triple therapy is recommended.
Read More
The Affordable Care Act: Implications for Clinical Practice and Research
May 21st 2013In "What Does the Affordable Care Act Actually Do?," presented by Ivor Douglas, MD, Associate Professor, University of Colorado Denver, Chief, Pulmonary Sciences and Critical Care Medicine Director, Medical Intensive Care, Denver Health Medical Center, at the ATS 2013 International Conference, Dr Douglas noted that fundamental issues driving the Affordable Care Act (ACA) include access, quality, and cost.
Read More
Dr Richard Channick, MD, Discusses Clinical Trial in Pulmonary Hypertension
May 21st 2013Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, spoke at the 2013 American Thoracic Society International Conference as part of a session featuring the Clinical Trials in Pulmonary Hypertension.
Read More
Dr. Richard Channick Addresses a New Treatment in Pulmonary Arterial Hypertension
May 21st 2013In this video, Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, speaks about the use of Macitentan for the treatment of pulmonary arterial hypertension (PAH).
Read More
Dr. Colin Cooke Highlights Healthcare Reform's Effects on Pulmonary Medicine
May 21st 2013Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI, says that hospitals with higher readmission rates that treat patients with acute myocardial infarction, congestive heart failure, and pneumonia will be penalized due to healthcare reform.
Read More
Hospital Readmissions: Challenges in Pulmonary Medicine Practice - Part 2
May 20th 2013The panel at the American Thoracic Society 2013 International Conference continued discussions that suggested high rates of hospital readmissions may be an indicator of poor initial treatment, or failure to coordinate care. Further, these rates, which varied dramatically from hospital to hospital, were often excessively expensive.
Read More
Choosing Wisely: Top Ways to Reduce Low-Value Care in Pulmonary and Critical Care
May 20th 2013Scott Halpern, MD, PhD, discussed the Choosing Wisely campaign with his opening presentation on The History of and Rationale for the Choosing Wisely Campaign. As most healthcare providers know, healthcare spending per capita in the United States is significantly higher than most other countries.
Read More
Dr. David Au Talks About Integrated Approaches to Systems of Care
May 20th 2013David Au, MD, Professor, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, says that hospital systems represent only one aspect of care delivery for patients who have been hospitalized.
Read More
Hospital Readmissions: Challenges in Pulmonary Medicine Practice - Part 1
May 19th 2013David H. Au, MD, MS, kicked off the Hospital Readmissions session at the American Thoracic Society 2013 conference with his presentation on Defining the Role of the Practitioner, Scientist and Policymaker. In the presentation, Dr Au says that it is important for all stakeholders in the healthcare industry to focus on hospital readmission rates.
Read More
When Conventional Drugs Aren't Enough: Enhancing the Immune System in Pulmonary Infections
May 19th 2013Dr Keertan Dheda's presentation at the American Thoratic Society 2013 International Conference, XDR TB: What Else Can We Do? focused on the growing epidemic of drug resistant tuberculosis (DR TB). Dr Dheda said there are about 25000 XDR TB global cases annually, and that DR TB can be very expensive to treat and manage.
Read More